These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2691149)

  • 1. The pathogenesis of systemic sclerosis.
    LeRoy EC
    Clin Exp Rheumatol; 1989; 7 Suppl 3():S135-7. PubMed ID: 2691149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines and human fibrosis.
    LeRoy EC; Trojanowska MI; Smith EA
    Eur Cytokine Netw; 1990; 1(4):215-9. PubMed ID: 1966552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast-matrix interactions and their role in the pathogenesis of fibrosis.
    Mauch C; Kreig T
    Rheum Dis Clin North Am; 1990 Feb; 16(1):93-107. PubMed ID: 2406813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transforming growth factor-beta and its receptors in scleroderma].
    QIAN H; ZHENG M
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):415-21. PubMed ID: 19693982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of pathogenesis in scleroderma. II. Effects of serum and conditioned culture medium on fibroblast function in scleroderma.
    Feghali CA; Boulware DW; Levy LS
    J Rheumatol; 1992 Aug; 19(8):1212-9. PubMed ID: 1404156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1.
    Shi-Wen X; Denton CP; Dashwood MR; Holmes AM; Bou-Gharios G; Pearson JD; Black CM; Abraham DJ
    J Invest Dermatol; 2001 Mar; 116(3):417-25. PubMed ID: 11231316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of p38 MAPK in transforming growth factor beta stimulation of collagen production by scleroderma and healthy dermal fibroblasts.
    Sato M; Shegogue D; Gore EA; Smith EA; McDermott PJ; Trojanowska M
    J Invest Dermatol; 2002 Apr; 118(4):704-11. PubMed ID: 11918720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis?
    Yamamoto T
    Arch Dermatol Res; 2006 Feb; 297(8):333-44. PubMed ID: 16402183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of c-myc proto-oncogene in scleroderma fibroblasts.
    Trojanowska M; Wu LT; LeRoy EC
    Oncogene; 1988 Oct; 3(4):477-81. PubMed ID: 3078955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connective tissue metabolism in scleroderma, including cytokines.
    Unemori EN; Amento EP
    Curr Opin Rheumatol; 1996 Nov; 8(6):580-4. PubMed ID: 9018463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of fibrosis in systemic scleroderma.
    Mauch C; Eckes B; Hunzelmann N; Oono T; Kozlowska E; Krieg T
    J Invest Dermatol; 1993 Jan; 100(1):92S-96S. PubMed ID: 8423407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenesis of systemic sclerosis].
    Fabri M; Krieg T
    Hautarzt; 2007 Oct; 58(10):838, 840-3. PubMed ID: 17786395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea.
    Vuorio T; Kähäri VM; Black C; Vuorio E
    J Rheumatol; 1991 Feb; 18(2):247-51. PubMed ID: 2023219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systemic sclerosis].
    Ihn H
    Nihon Rinsho; 2009 Mar; 67(3):519-22. PubMed ID: 19280926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
    J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible role for transforming growth factor-beta in systemic sclerosis.
    Smith EA; LeRoy EC
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):125S-127S. PubMed ID: 2258629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connective tissue metabolism including cytokines in scleroderma.
    Smith EA
    Curr Opin Rheumatol; 1992 Dec; 4(6):869-77. PubMed ID: 1457283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the pathogenesis of systemic sclerosis.
    Tamby MC; Chanseaud Y; Guillevin L; Mouthon L
    Autoimmun Rev; 2003 May; 2(3):152-7. PubMed ID: 12848956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic sclerosis: pathophysiology of a multifaceted disease].
    Servettaz A; Agard C; Tamby MC; Guilpain P; Guillevin L; Mouthon L
    Presse Med; 2006 Dec; 35(12 Pt 2):1903-15. PubMed ID: 17159716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of scleroderma (systemic sclerosis).
    LeRoy EC
    J Invest Dermatol; 1982 Jul; 79 Suppl 1():87s-89s. PubMed ID: 7086194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.